Hospitals and universities repurposing drugs at 90% lower cost
Research from King’s College London highlights a 'hidden' system where hospitals and universities repurpose existing drugs for new treatments at a fraction of the cost of pharmaceutical industry trials. This approach bypasses traditional patent-driven models to provide affordable medical solutions.
Why it matters
This alternative research model could significantly lower healthcare costs and increase access to life-saving treatments by leveraging existing, well-studied medications.
Universities and hospitals are repurposing existing drugs through late-stage trials with funded costs up to 90% lower than those taking place in the pharmaceutical industry.
The article presents research findings objectively, focusing on the methodology and potential societal benefits.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in